Niagen Bioscience, Inc. (NAGE) Tops Q2 EPS by 2c

Niagen Bioscience, Inc. (NASDAQ: NAGE) reported Q2 EPS of $0.04, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter came in at $31.1 million versus the consensus estimate of $28.36 million.

For earnings history and earnings-related data on Niagen Bioscience, Inc. (NAGE) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• TD Cowen Resumes IsoEnergy Ltd (ISO:CN) at Buy
• JPMorgan Downgrades Kuaishou Technology (1024:HK) to Neutral